Not a strong “buy right now” for an impatient entry: momentum/trend is neutral and Intellectia signals are absent.
If you must act immediately, CHRD is closer to support than resistance (better risk/reward than chasing strength), but the setup is still only a “selective nibble,” not a high-conviction buy.
Bullish lean from options positioning and news-driven insider-bullish narrative supports downside being somewhat buffered, yet fundamentals are in a YoY down-cycle and analyst targets have been cut.
Activity: today’s volume (613) is elevated vs 30-day average (~281% of avg), signaling increased attention.
Volatility: IV30 ~38.65 vs HV ~37.14 with IV percentile ~25 and IV rank ~14.9 → options are not expensive relative to recent history (less “fear premium” priced in).
Overall: fundamentals are in a downshift versus last year; the bull case relies more on capital discipline/dividends and a commodity-cycle stabilization than on near-term earnings growth.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: multiple firms lowered price targets in January 2026 (Wells Fargo 113→109, Morgan Stanley 123→114, Jefferies 101→99, Scotiabank 120→114, UBS 123→119, Mizuho 150→148) → Street is de-risking expectations as oil macro weakens.
Ratings mix: still contains bullish stances (Wells Fargo Overweight, UBS Buy, Mizuho Outperform, William Blair Outperform initiation), but also several “middle” ratings (Morgan Stanley Equal Weight, Jefferies Hold, Scotiabank Sector Perform) and a downgrade (Pickering to Neutral).
Wall Street pros: capital discipline/low reinvestment model, solid FCF/dividend framework, perceived undervaluation vs peers.
Wall Street cons: macro oversupply/price pressure, weaker near-term cash flow/realizations, and reduced target confidence into 2026 guidance.
Wall Street analysts forecast CHRD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHRD is 129.27 USD with a low forecast of 105 USD and a high forecast of 165 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast CHRD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHRD is 129.27 USD with a low forecast of 105 USD and a high forecast of 165 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
3 Hold
0 Sell
Strong Buy
Current: 98.470
Low
105
Averages
129.27
High
165
Current: 98.470
Low
105
Averages
129.27
High
165
Wells Fargo
Overweight
downgrade
$113 -> $109
AI Analysis
2026-01-27
Reason
Wells Fargo
Price Target
$113 -> $109
AI Analysis
2026-01-27
downgrade
Overweight
Reason
Wells Fargo lowered the firm's price target on Chord Energy to $109 from $113 and keeps an Overweight rating on the shares. The oil macro remains pressured, with downside-skewed fundamentals as rising OPEC supply and strong non-OPEC growth point to a near-term surplus and continued price pressure, Wells notes. Amid a softer macro, the firm favors low-reinvestment, capital-disciplined frameworks, with 2026 plans broadly stable across the group.
Morgan Stanley
Devin McDermott
Equal Weight
downgrade
$123 -> $114
2026-01-23
Reason
Morgan Stanley
Devin McDermott
Price Target
$123 -> $114
2026-01-23
downgrade
Equal Weight
Reason
Morgan Stanley analyst Devin McDermott lowered the firm's price target on Chord Energy to $114 from $123 and keeps an Equal Weight rating on the shares. The firm marked its 2026-27 oil price deck for strip as of January 7 in conjunction with its Q4 preview for the E&Ps, oil majors and Canadian producers. The firm expects "fairly clean" Q4 operational updates but lighter cash flow from price realizations, the analyst tells investors in the preview.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CHRD
